Inve India ▾

Inventurus Knowledge Solutions share price & results

Inventurus Knowledge Solutions Limited· Information Technology

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

AI-and-human RCM, clinical documentation and value-based-care outsourcing for U.S. healthcare providers.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue475 ₹ crore+48.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin46.0 %−1.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit163 ₹ crore+44.2% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity33.29 %−1.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin19.22 %+8.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)21.13 %−26.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

3 of 8 judged targets kept · 6 open · verdicts reflect calls analysed to Q1 FY27.

Inventurus Knowledge Solutions Limited management guidance track record on Inve: 14 targets tracked across analysed earnings calls (3 achieved, 5 missed, 6 open).

TargetOriginal wordingSaidLatest callVerdict
Consolidated EBITDA Marginearly to mid-30s consolidated EBITDA margins perhaps over the next 18 to 24 months.
Call transcript, Q3 FY25 · 6 Feb 2025
Q3 FY25Q1 FY27:Legacy IKS business reported 33% EBITDA margin, adjusted to 35% for one-time costs, continuing to meet the 'mid-30s' target. This promise is now superseded by the new combined entity margin guidance.
Call transcript, Q1 FY27 · 6 Aug 2026
Achieved
Net Debtget debt free sometime next fiscal [FY26].
Call transcript, Q3 FY25 · 6 Feb 2025
Q3 FY25Q1 FY27:Promise remains missed and has been superseded by the new post-acquisition deleveraging target (`net-debt-zero-post-acquisition`).
Call transcript, Q1 FY27 · 6 Aug 2026
Missed
Revenue Growthwell north of that 12% that the outsourced TAM is growing at.
Call transcript, Q3 FY25 · 6 Feb 2025
Q3 FY25Q1 FY27:Reported 21% YoY growth (12% in constant currency). Management reiterated a '12%-plus growth aspiration' for the legacy IKS book. While 12% CC meets the revised aspiration, it is not 'well north' of the original target. Still considered on track due to strong reported growth.
Call transcript, Q1 FY27 · 6 Aug 2026
On Track

Source: Inve Guidance Tracker for Inventurus Knowledge Solutions Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

5 of Inventurus Knowledge Solutions Limited's 14 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,703 +2.60% · +₹43.1

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +11.5% 1Y

₹1.4k₹1.6k₹1.8kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 6 Nov 2025Q3 FY26 — 5 Feb 2026Q3 FY26 — 29 Apr 2026Q1 FY27 — 6 Aug 2026

1Y: ₹1,527 on 24 Oct 2025 → ₹1,703. High ₹1,937.8 (23 Sept 2026), low ₹1,274.9 (23 Mar 2026).

Previous close
₹1,659.9
Market cap
₹29.3k Cr
52-week range
₹1,274.9 – ₹1,937.8
One year
+11.73%
Price to earnings (TTM to Jun 2026)
38.30×
Return on equity (TTM to Jun 2026)
33.29%

Overview

Symbol
NSE:IKS
Exchange
NSE
Currency
INR

What Inventurus Knowledge Solutions Limited does

Based on the company's own presentations, annual report and earnings calls.

IKS Health provides technology-enabled revenue cycle management, clinical documentation and care-management services to hospitals, health systems and physician groups across the United States, positioning itself as a combined 'system of action' platform layered on top of clients' electronic health records. It handles the pre-visit, during-visit, post-visit and between-visit workflow for clinicians - scheduling, patient financial clearance, ambient clinical documentation, medical coding, billing, denial prevention and inbox/care management - through a mix of AI/GenAI tools and dedicated clinical, coding and technology staff operating out of global delivery centers. It also supports inpatient/acute settings with clinical documentation, coding, revenue optimization and discharge support, and offers value-based-care solutions for organizations managing risk-based contracts. Revenue is earned on a percentage-of-collections basis or a per-physician-per-month SaaS-based pricing model.

Segments

  • Revenue Optimization
  • Clinical Support
  • Value-Based Care
Healthcare organization clients
700+
Clinicians served
150,000+
Global delivery centers
7
Offices worldwide
17 offices across 4 countries and 3 continents
India offices
12 offices across 7 cities
Top-5 client relationship tenure
8.57 years average
Founded 2006Headquarters Navi Mumbai, Maharashtra, IndiaEmployees 12,661 (FY2024-25 (Annual Report) Company website

How the price took the results

close before → close after

Q1 FY27
−6.1%
6 Aug
Q3 FY26
+5.9%
5 Feb
Q2 FY26
+0.1%
6 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Inventurus Knowledge Solutions Limited

Free account: one company. Everything above stays public.

Write why you follow Inventurus Knowledge Solutions Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds